adenovirus
ad
gain
popular
gene
deliveri
vector
therapeut
prophylact
applic
ad
entri
host
cell
involv
specif
interact
cell
surfac
receptor
viral
capsid
protein
sever
cell
surfac
molecul
identifi
receptor
ad
attach
entri
tissu
tropism
ad
vector
greatli
influenc
receptor
usag
varieti
strategi
investig
modifi
ad
vector
tropism
manipul
receptorinteract
moieti
mani
strategi
aim
target
andor
detarget
ad
vector
review
discuss
variou
cell
surfac
molecul
implic
receptor
viru
attach
intern
special
emphasi
given
ad
type
util
gene
deliveri
vector
variou
strategi
modifi
ad
tropism
use
knowledg
ad
receptor
also
discuss
adenovirus
ad
nonenvelop
doublestrand
dna
virus
famili
adenovirida
berk
wold
horwitz
viral
particl
nm
diamet
icosahedr
symmetri
contain
linear
genom
kb
hspg
fleischli
et
al
segerman
et
al
short
et
al
sirena
et
al
tuve
et
al
renal
receptor
x
hspg
fleischli
et
al
segerman
et
al
segerman
et
al
short
et
al
tuve
et
al
c
respiratori
car
hspg
mhci
vcami
integrin
bergelson
et
al
chu
et
al
dechecchi
et
al
wickham
et
al
ocular
car
sialic
acid
arnberg
et
al
roelvink
et
al
e
respiratori
ocular
car
roelvink
et
al
f
gastrointestin
car
roelvink
et
al
list
receptor
suggest
use
one
serotyp
subgroup
bird
amphibian
reptil
davison
et
al
serotyp
classifi
six
distinct
subgroup
speci
af
base
hemagglutin
properti
oncogen
potenti
newborn
hamster
genom
organ
dna
homolog
berk
fauquet
et
al
subgroup
b
subdivid
subspeci
basi
restrict
enzym
digest
pattern
genom
differ
tissu
tropism
segerman
et
al
wadel
et
al
immunocompet
individu
had
involv
mostli
mild
selflimit
diseas
wherea
children
immunocompromis
adult
diseas
may
acut
even
lifethreaten
kojaoghlanian
et
al
gener
had
differ
subgroup
exhibit
distinct
tissu
tropism
clinic
manifest
tabl
typic
subgroup
c
e
mainli
caus
respiratori
tract
infect
wherea
subgroup
e
lead
ocular
infect
russel
serotyp
subgroup
f
respons
gastrointestin
infect
subgroup
had
caus
renal
urinari
tract
infect
russel
likewis
ad
nonhuman
origin
also
show
distinct
tissu
tropism
initi
attach
ad
primari
receptor
differ
among
ad
subgroup
tabl
consid
one
primari
determin
ad
tropism
ad
gener
immens
interest
vector
therapeut
gene
deliveri
serotyp
extens
studi
commonli
use
ad
serotyp
gene
deliveri
applic
date
mani
preclin
studi
well
clinic
trial
variabl
encourag
result
conduct
current
progress
http
wwwwileycoukgenetherapyclin
septemb
nearli
percent
gene
therapi
clinic
trial
approv
worldwid
util
ad
vector
direct
toward
cancer
gene
therapi
http
wwwwileyco
ukgenetherapyclin
popular
ad
vector
base
sever
advantag
effici
transgen
deliveri
express
transduct
divid
nondivid
cell
eas
propag
high
titer
episom
persist
ad
genom
within
nucleu
minim
risk
genom
insert
mutagenesi
rel
stabil
blood
follow
system
administr
high
capac
accommod
foreign
dna
signific
progress
understand
biolog
ad
dougla
wu
et
al
howev
despit
aforement
advantag
clinic
applic
ad
vector
limit
sever
disadvantag
strong
immunogen
ad
vector
preval
preexist
antihad
immun
human
popul
lack
specif
target
rapid
bloodclear
predomin
hepatotrop
follow
system
administr
dougla
wu
et
al
ad
entri
host
cell
mediat
two
main
event
initi
step
viru
attach
primari
cell
surfac
receptor
knob
domain
viral
fiber
follow
secondari
interact
viral
capsid
compon
intern
receptor
leopold
crystal
varieti
serotyp
nonhuman
ad
sever
cellular
receptor
identifi
propos
zhang
bergelson
identif
cellular
receptor
use
ad
necessari
better
understand
viral
pathogenesi
well
develop
novel
adbas
gene
deliveri
vector
review
discuss
variou
ad
receptor
implic
ad
tropism
variou
strategi
modifi
adreceptor
interact
develop
novel
ad
vector
alter
tropism
greater
efficaci
safeti
coxsackievirusadenoviru
receptor
kda
type
transmembran
glycoprotein
initi
identifi
high
affin
attach
receptor
coxsackieviru
b
well
serotyp
bergelson
et
al
tomko
et
al
car
belong
cortic
thymocyt
marker
xenopu
ctx
subfamili
immunoglobulin
ig
superfamili
consist
two
extracellular
iglik
domain
distal
variabl
proxim
singlepass
hydrophob
transmembran
domain
long
carboxytermin
cytoplasm
domain
chretien
et
al
wang
bergelson
among
domain
domain
alon
suffici
interact
ad
fiber
knob
kirbi
et
al
wang
bergelson
gener
knobcar
interact
serv
attach
virion
host
cell
surfac
subsequ
viru
endocytosi
promot
interact
viruscar
complex
addit
coreceptor
integrin
wickham
et
al
howev
integrinindepend
viru
intern
though
slower
rate
also
report
shayakhmetov
et
al
addit
mani
serotyp
subgroup
e
f
subgroup
b
recogn
car
roelvink
et
al
sever
ad
vector
deriv
nonhuman
speci
also
investig
altern
vector
gene
deliveri
applic
bangari
mittal
mani
vector
canin
chimpanze
avian
ad
shown
interact
car
bovin
porcin
ovin
ad
appear
enter
cell
carindepend
manner
bangari
mittal
bangari
et
al
cohen
et
al
glasgow
et
al
soudai
et
al
tan
et
al
suscept
particular
cell
type
infect
found
correl
express
level
car
asaoka
et
al
fux
et
al
hemmi
et
al
li
et
al
moreov
induc
express
car
varieti
cell
type
natur
refractori
ad
infect
show
improv
transduct
nalbantoglu
et
al
transgen
mice
express
car
select
tissu
also
show
enhanc
ad
transduct
target
cell
bao
et
al
homologu
human
car
present
sever
speci
includ
mice
rat
dog
pig
high
level
homolog
fechner
et
al
tomko
et
al
tissu
distribut
car
quit
complex
development
regul
philipson
pettersson
though
suffici
level
mrna
encod
car
observ
variou
tissu
tomko
et
al
tomko
et
al
highest
level
report
embryon
tissu
gradual
declin
birth
tissu
raschperg
et
al
polar
epitheli
cell
car
preferenti
express
basolater
surfac
absent
apic
surfac
may
limit
viru
infect
across
epitheli
surfac
cohen
et
al
walter
et
al
zabner
et
al
studi
local
car
tight
junction
andor
adheren
junction
associ
zonula
tight
junction
protein
engag
homotyp
cellcel
interact
adhes
tissu
genesi
cohen
et
al
raschperg
et
al
cardefici
mice
die
embryon
stage
due
defect
cardiac
develop
indic
import
car
organogenesi
embryon
develop
chen
et
al
dorner
et
al
spite
wide
variat
fiber
knob
amino
acid
sequenc
among
serotyp
compar
amino
acid
residu
involv
carbind
wellconserv
among
carbind
serotyp
sequenc
analysi
mutagenesi
studi
key
carbind
residu
carbind
serotyp
identifi
side
monom
trimer
knob
kirbi
et
al
roelvink
et
al
crystal
structur
fiber
knob
complex
domain
car
identifi
critic
region
knob
carbind
car
molecul
bind
interfac
two
adjac
knob
monom
consist
observ
neutral
antibodi
direct
trimer
knob
howev
adjac
monom
may
contribut
carbind
monom
trimer
knob
independ
bind
car
kirbi
et
al
carbind
serotyp
also
conserv
residu
carbind
similar
crystal
structur
compar
roelvink
et
al
roelvink
et
al
hand
noncarbind
serotyp
either
lack
conserv
carbind
residu
chargester
hindranc
hamper
knobcar
interact
burmeist
et
al
durmort
et
al
davidson
leissner
et
al
shaft
domain
impart
ad
fiber
protein
length
also
determin
flexibl
chroboczek
et
al
ruigrok
et
al
differ
ad
serotyp
exhibit
differ
fibershaft
length
depend
number
pseudorepeat
within
shaft
gener
shorter
rigid
fiber
hinder
ad
bind
car
well
secondari
interact
integrin
chroboczek
et
al
shayakhmetov
lieber
interestingli
charg
hypervari
region
hvr
hexon
also
influenc
ad
interact
receptor
crawfordmiksza
schnurr
observ
implic
complex
natur
adcar
interact
pauciti
car
surfac
mani
primari
cancer
cell
refractori
transduct
carbind
ad
vector
kim
et
al
car
express
level
cancer
tissu
invers
correl
tumor
aggress
induct
car
highli
tumorigen
cancer
cell
tumor
suppressor
effect
observ
also
highlight
need
ad
vector
carindepend
intern
cancer
gene
therapi
integrin
noncoval
associ
heterodimer
cell
surfac
adhes
molecul
compos
subunit
play
critic
role
number
host
cell
function
includ
cell
attach
migrat
growth
differenti
luo
et
al
stewart
nemerow
eighteen
differ
subunit
eight
subunit
form
twenti
heterodim
stewart
nemerow
integrin
ubiquit
express
wide
varieti
cell
broad
rang
microbi
pathogen
recogn
invad
host
cell
hyne
stewart
nemerow
multipl
type
integrin
molecul
includ
vitronectin
receptor
wickham
et
al
well
li
et
al
salon
et
al
shown
act
secondari
receptor
mani
ad
integrin
interact
argglyasp
rgd
leuaspval
ldv
motif
display
expos
loop
ad
penton
base
gener
adintegrin
interact
rel
low
affin
therefor
high
affin
primari
fiberreceptor
interact
crucial
effici
ad
infect
sequenc
serotyp
except
contain
rgd
motif
penton
base
like
use
integrin
coreceptor
albinsson
kidd
cytoplasm
domain
subunit
integrin
interact
varieti
signal
molecul
therefor
adintegrin
interact
promot
activ
crkassoci
substrat
phosphatidylinositol
kinas
rho
famili
small
gtpase
result
actin
polymer
cytoskelet
rearrang
enhanc
ad
intern
receptormedi
endocytosi
cryoelectron
microscop
structur
analys
complex
integrin
reveal
bind
penton
base
rgd
motif
chiu
et
al
mathia
et
al
structur
find
also
suggest
pentamer
spatial
arrang
rgd
motif
penton
base
necessari
receptor
cluster
initi
cellsign
event
requir
viru
intern
besid
intern
integrin
play
major
role
membran
permeabil
viru
escap
cytosol
majhen
et
al
wickham
et
al
ad
vector
penton
base
rgd
motif
delet
show
delay
uptak
also
result
slow
endosom
escap
shayakhmetov
et
al
member
integrin
famili
led
attach
fiberless
particl
cardefici
monocyt
cell
follow
secondari
interact
integrin
huang
et
al
order
overcom
limit
express
primari
ad
receptor
strategi
base
incorpor
addit
rgd
motif
ad
fiber
knob
use
enhanc
ad
transduct
wide
varieti
cell
includ
endotheli
cell
smooth
muscl
fibroblast
numer
tumor
cell
type
dendrit
cell
dc
express
low
level
car
high
level
integrin
hidaka
et
al
majhen
ambriovicristov
okada
et
al
staba
et
al
wickham
et
al
membran
cofactor
protein
mcp
ubiquit
express
type
transmembran
glycoprotein
biolog
function
prevent
complement
activ
autolog
tissu
bind
inactiv
mainli
consist
aminotermin
extracellular
domain
compris
four
modul
term
short
consensu
repeat
scr
scr
scr
ii
scr
iii
scr
iv
one
three
serthrpro
stp
rich
domain
short
region
unknown
function
hydrophob
transmembran
domain
carboxytermin
cytoplasm
tail
russel
owe
altern
rna
splice
stp
region
cytoplasm
domain
four
major
isoform
addit
minor
splice
variant
coexpress
tissu
interestingli
also
refer
pathogen
magnet
sinc
besid
subgroup
b
had
also
act
receptor
number
human
pathogen
measl
viru
herpesviru
bovin
viral
diarrhea
viru
streptococcu
pyogen
neisseria
gonorrhoea
n
meningitid
helicobactor
pylori
recogn
differ
structur
ectodomain
cattaneo
lindahl
et
al
earlier
studi
demonstr
neither
subgroup
b
had
crosscompet
virion
serogroup
c
e
f
cell
receptor
interact
solubl
recombin
car
suggest
util
differ
cellular
receptor
intern
akiyama
et
al
defer
et
al
stevenson
et
al
subsequ
identifi
cellular
receptor
major
subgroup
b
had
includ
subspeci
subspeci
fleischli
et
al
gaggar
et
al
segerman
et
al
b
sirena
et
al
usag
remain
controversi
fleischli
et
al
gustafsson
et
al
marttila
et
al
tuve
et
al
discrep
could
due
variat
cell
type
express
level
differ
isoform
involv
addit
receptor
suggest
engag
via
similar
bind
site
antibodi
solubl
competit
experi
show
differ
bind
fleischli
et
al
addit
subgroup
had
eg
also
suggest
use
attach
receptor
lemckert
et
al
wu
et
al
antibodi
map
competit
assay
use
mutant
crystal
structur
knob
complex
knobbind
region
unravel
interact
subgroup
b
had
demonstr
scr
ii
domain
crucial
bind
infect
fiberbear
vector
although
scr
also
requir
maintain
scr
ii
conform
favor
viru
bind
sakurai
et
al
shayakhmetov
et
al
crystallograph
studi
shown
bind
accompani
profound
chang
conform
get
straighten
rodlik
shape
bent
nativ
form
conform
chang
expos
hidden
residu
bind
knob
three
major
contact
region
design
b
c
within
hi
dg
ij
loop
knob
togeth
residu
critic
identifi
persson
et
al
critic
residu
fiber
knob
like
involv
also
identifi
power
et
al
crystal
structur
fiber
knob
solv
model
fiber
knob
complex
gener
pach
et
al
despit
certain
structur
differ
region
ad
exhibit
similar
bind
mechan
affin
numer
studi
suggest
exist
addit
receptor
subgroup
b
had
marttila
et
al
segerman
et
al
tuve
et
al
ident
addit
receptor
distinct
remain
elus
refer
speci
b
receptor
sbar
receptor
x
elus
receptor
express
high
level
human
mesenchym
undifferenti
embryon
stem
cell
well
varieti
tumor
cell
line
potenti
target
gene
therapi
stem
cell
research
tuve
et
al
altern
classif
subgroup
b
had
base
receptor
usag
also
propos
tuve
et
al
group
had
almost
exclus
use
group
ii
had
util
receptor
x
group
iii
use
receptor
x
chimpanze
ad
type
close
relat
subgroup
had
unlik
chimpanze
ad
serotyp
util
cell
entri
car
tatsi
et
al
vector
deriv
subgroup
b
had
pseudotyp
chimer
vector
fiber
subgroup
b
had
effici
transduc
cell
type
refractori
transduct
tradit
vector
includ
malign
cancer
cell
hematopoiet
mesenchym
stem
cell
smooth
muscl
cell
human
bone
marrow
stromal
cell
synoviocyt
lymphocyt
dc
ad
vector
util
receptor
demonstr
reduc
abil
induc
interleukin
il
proinflammatori
cytokin
compar
carutil
ad
therebi
dampen
immun
respons
ad
iacobellimartinez
et
al
therefor
vector
could
significantli
improv
durat
transgen
express
target
tissu
lack
express
rodent
cell
low
homolog
human
rodent
rodent
serv
ideal
model
subgroup
b
had
transgen
mous
model
express
profil
similar
monkey
human
suggest
suitabl
preclin
model
ad
vector
sakurai
et
al
tatsi
et
al
verhaagh
et
al
type
glycoprotein
member
ig
superfamili
compris
two
extracellular
iglik
domain
link
transmembran
domain
cytoplasm
tail
greenwald
et
al
express
surfac
antigenpres
cell
apc
includ
dc
b
lymphocyt
act
costimulatori
signal
activ
cellmedi
immun
respons
bind
cytotox
lymphocyt
molecul
greenwald
et
al
member
subgroup
b
had
ad
specif
bind
infect
cell
express
short
et
al
short
et
al
tropism
subgroup
b
had
cell
hematopoiet
origin
neoplast
cell
due
high
level
express
cell
davidoff
et
al
kanerva
et
al
knaanshanz
et
al
rea
et
al
short
et
al
sinc
dc
potent
apc
upregul
molecul
matur
dc
enhanc
transduct
subgroup
b
had
highlight
potenti
vector
vaccin
cancer
gene
therapi
furthermor
transduct
dc
may
also
allow
ad
vector
escap
host
immun
surveil
modul
host
immun
respons
rea
et
al
howev
effect
ad
transduct
biolog
function
implic
cell
immun
respons
still
unknown
distinct
unknown
receptor
x
subgroup
b
had
tuve
et
al
involv
addit
receptor
x
receptor
ad
intern
add
complex
receptor
usag
subgroup
b
had
understand
subgroup
b
intern
pave
way
design
novel
ad
vector
gene
deliveri
sialic
acid
refer
osubstitut
deriv
neuramin
acid
usual
found
gangliosid
glycoprotein
due
neg
charg
extern
posit
glycoprotein
gangliosid
well
outer
cell
membran
sialic
acid
potenti
critic
compon
ligand
recognit
specif
virus
sialic
acid
known
use
influenza
viru
rotaviru
coronaviru
polyomaviru
cellular
receptor
although
virus
greatli
differ
interact
sialic
acid
dormitz
et
al
stehl
harrison
wei
et
al
sever
member
subgroup
had
tropism
eye
frequent
associ
epidem
keratoconjunct
ekc
bell
et
al
bennett
et
al
hierholz
et
al
liszewski
et
al
rekhter
et
al
ekccaus
serotyp
demonstr
use
sialic
acid
cellular
receptor
arnberg
et
al
arnberg
et
al
b
contrari
close
relat
subgroup
had
caus
ekc
neither
use
sialic
acid
receptor
predict
isoelectr
point
knob
sialic
acidbind
serotyp
least
log
higher
had
impli
electr
charg
play
key
role
knobsial
acid
interact
arnberg
et
al
bind
sialic
acid
shown
sensit
salt
neg
charg
compound
support
import
electr
charg
adreceptor
interact
arnberg
et
al
knob
without
ocular
tropism
differ
knob
ocular
tropism
two
posit
result
partial
loss
unusu
high
posit
charg
knob
burmeist
et
al
huang
et
al
amino
acid
align
crystal
structur
subgroup
had
reveal
conserv
sialic
acidbind
site
locat
top
knob
overlap
carbind
site
side
knob
burmeist
et
al
base
find
multival
sialic
acid
demonstr
aggreg
neutral
virion
propos
potenti
antivir
drug
treatment
ekc
johansson
et
al
furthermor
sialic
acid
util
ad
chimer
vector
fiberknob
deriv
subgroup
ad
demonstr
expand
tropism
cell
type
hematopoiet
cell
includ
dc
otherwis
consid
refractori
transduct
carutil
vector
proteoglycan
pg
ubiquit
express
glycoprotein
consist
protein
core
one
coval
attach
glycosaminoglycan
gag
chain
gag
long
neg
charg
linear
carbohydr
polym
variabl
sulfat
repeat
disaccharid
unit
pg
form
major
compon
extracellular
matrix
ecm
involv
numer
biolog
function
cellular
attach
prolifer
differenti
embryon
develop
blood
coagul
receptormedi
endocytosi
bishop
et
al
wide
preval
pg
sever
pathogen
evolv
exploit
attach
intern
receptor
heparan
sulfat
proteoglycan
hspg
shown
involv
attach
infect
consensu
hspgbind
sequenc
lyslysthrli
kktk
motif
fiber
shaft
suggest
respons
viru
interact
cell
surfac
hspg
dechecchi
et
al
dechecchi
et
al
sinc
hepatocyt
rich
surfac
express
hspg
enhanc
liver
transduct
attribut
fibershaft
kktk
motif
hspg
interact
mutat
put
hspgbind
motif
ad
result
signific
reduct
liver
transduct
smith
et
al
b
reduct
transduct
pronounc
kktk
mutat
combin
car
andor
integrinbind
ablat
nicol
et
al
howev
ad
hepatotrop
appear
receptorindepend
ablat
car
andor
integrinbind
result
signific
reduct
liver
transduct
despit
decreas
transduct
hepatocyt
vitro
nicklin
et
al
despit
sever
studi
hspg
ad
interact
still
clear
evid
implic
role
kktk
motif
livertarget
ad
vector
moreov
ad
fiber
kktk
motif
experiment
shown
bind
hspg
ad
vector
found
associ
hspg
due
remark
poor
hepatotrop
kktk
mutant
vector
initi
appear
good
candid
develop
retarget
vector
unabl
effici
transduc
suscept
cell
vitro
vivo
smith
et
al
b
furthermor
incorpor
retarget
ligand
integrinbind
rgd
motif
endotheli
cell
target
glnprogluhisserserthr
qpehsst
peptid
hi
loop
shaftmut
ad
fiber
fail
improv
viru
infect
cell
line
express
high
level
integrin
endotheli
cell
bayopuxan
et
al
kritz
et
al
diminish
retarget
could
either
due
effect
mutat
fiber
structur
andor
stabil
presum
kktk
motif
posit
adjac
flexibilityimpart
domain
fiber
shaft
mutat
kktk
motif
might
interfer
postattach
process
virion
endocytosi
endosom
lysi
escap
nuclear
transloc
di
paolo
et
al
kritz
et
al
sinc
kktk
mutant
ad
show
attenu
transduct
suscept
cell
di
paolo
et
al
employ
indirect
altern
strategi
investig
potenti
role
kktk
motif
liver
transduct
gener
fibershaft
chimer
vector
possess
fibershaft
domain
deriv
lack
kktk
motif
could
recogn
car
attach
receptor
di
paolo
et
al
reduct
effici
liver
transduct
fibershaft
chimer
vector
observ
compar
unmodifi
vector
suggest
kktk
motifhspg
interact
unlik
mediat
ad
hepatotrop
clearli
studi
necessari
elucid
exact
role
kktk
motif
variou
step
viru
entri
suggest
altern
carindepend
pathway
certain
blood
factor
see
act
bridg
link
ad
hepatocellular
hspg
lowdens
lipoprotein
ldl
receptorrel
protein
mediat
enhanc
liver
transduct
shayakhmetov
et
al
recent
studi
identifi
hspg
low
affin
sulfationdepend
ligand
subgroup
b
had
tuve
et
al
interact
hspg
via
knob
interact
hspg
via
unknown
viral
protein
observ
pg
absolut
requir
viru
attach
instead
vector
exploit
ubiquit
hspg
order
gain
better
access
high
affin
prefer
attach
receptor
receptor
x
remark
differ
bind
affin
suggest
hspg
like
repres
unidentifi
receptor
x
subgroup
b
had
major
histocompat
complex
class
mhci
molecul
cell
surfac
peptidebind
antigenpres
glycoprotein
consist
polymorph
heavi
chain
noncoval
link
invari
chain
bjorkman
parham
revers
antibodi
biopan
phage
display
librari
employ
identifi
mimotop
fiber
protein
receptor
domain
heavi
chain
mhci
propos
involv
primari
bind
fiber
express
mhci
lymphoblastoid
cell
line
result
increas
fiber
bind
admedi
gene
transfer
compar
cell
lack
mhci
express
howev
involv
mhci
ad
attach
suscept
cell
remain
unclear
davison
et
al
mcdonald
et
al
human
leukocyt
antigen
hla
human
mhc
system
car
coexpress
chines
hamster
ovari
cho
cell
found
fiber
bound
singl
high
affin
car
receptor
hla
davison
et
al
suggest
mhci
molecul
may
play
role
ad
attach
intern
absenc
low
avail
car
altern
mhci
directli
indirectli
assist
increas
car
access
ad
fiber
davison
et
al
vascular
cell
adhes
type
membran
sialoglycoprotein
express
cytokineactiv
endothelium
mediat
leukocyteendotheli
cell
adhes
signal
transduct
may
play
role
develop
atherosclerosi
osborn
et
al
similar
car
also
ig
superfamili
protein
share
modest
level
homolog
car
chu
et
al
admedi
gene
transfer
vascular
endothelium
observ
effect
atherosclerot
vessel
compar
undamag
vessel
ooboshi
et
al
rekhter
et
al
increas
surfac
express
atherosclerot
vessel
suggest
respons
part
augment
ad
transduct
chu
et
al
constitut
express
murin
fibroblast
nih
cell
result
modest
increas
ad
bind
compar
infect
parent
nih
cell
chu
et
al
unidentifi
molecul
ig
superfamili
share
homolog
car
could
possibl
act
auxiliari
lowaffin
receptor
may
assist
improv
admedi
gene
transfer
cardefici
cell
vivo
tropism
ad
differ
remark
vitro
tropism
cell
cultur
system
ad
follow
classic
twostep
process
intern
vivo
multitud
host
factor
significantli
modul
tropism
biodistribut
system
inocul
ad
vector
increas
transduct
hepatocyt
follow
system
administr
appear
independ
ad
primari
receptor
abolit
carandor
integrinad
interact
success
modifi
ad
tropism
nicklin
et
al
shayakhmetov
et
al
util
situ
liver
perfus
techniqu
investig
admedi
hepatocyt
transduct
presenc
absenc
blood
demonstr
coagul
factor
ix
complement
compon
protein
bind
ad
fiber
knob
act
link
viru
uptak
hepatocyt
hspg
ldl
receptorrel
protein
shayakhmetov
et
al
furthermor
mutat
fiber
knob
ablat
blood
factorbind
significantli
reduc
transduct
liver
cell
shayakhmetov
et
al
subsequ
studi
addit
vitamin
kdepend
blood
coagul
factor
fvii
fix
fx
protein
c
share
common
domain
structur
implic
transduct
hepatocyt
parker
et
al
downregul
vitamin
kdepend
zymogen
warfarin
result
remark
reduct
hepatocellular
transduct
fx
infus
restor
ad
transduct
hepatocyt
parker
et
al
recent
two
independ
studi
util
cryoelectron
microscopi
surfac
plasmon
reson
analysi
demonstr
hexon
protein
fiber
protein
bind
fx
interact
mainli
respons
ad
local
hepatocyt
kalyuzhniy
et
al
waddington
et
al
fxbind
site
identifi
hvr
hexon
protein
mutat
hexon
swap
hvr
nonfxbind
ad
serotyp
result
substanti
reduct
liver
tropism
kalyuzhniy
et
al
waddington
et
al
also
suggest
fx
form
mesh
cover
ad
surfac
may
steric
inhibit
fibermedi
interact
receptor
signific
variat
among
ad
serotyp
abil
bind
fx
correl
abil
transduc
hepatocyt
find
provid
new
insight
regard
hepatotrop
ad
vector
investig
direct
would
pave
way
develop
safe
tissuespecif
ad
vector
gene
deliveri
system
administr
necessari
har
full
potenti
ad
vector
gene
deliveri
applic
vitro
tropism
ad
vector
necessarili
correl
vivo
tropism
moreov
natur
tropism
ad
usual
alway
match
therapeut
requir
sever
investig
develop
strategi
ablat
nativ
tropism
ad
vector
introduc
novel
tropism
toward
target
cell
numer
strategi
retarget
ad
vector
propos
investig
variabl
efficaci
tabl
one
approach
physic
target
viru
surfac
coat
polym
polyethylen
glycol
poli
n
methacrylamid
phpma
biodegrad
algin
microparticl
croyl
et
al
fisher
et
al
kreppel
kochanek
sailaja
et
al
modif
ablat
nativ
tropism
vector
besid
shield
host
immun
respons
select
target
could
achiev
attach
varieti
target
ligand
peptid
protein
antibodi
polym
eto
et
al
kreppel
kochanek
morrison
et
al
stevenson
et
al
anoth
effect
strategi
physic
target
use
bispecif
adaptor
molecul
includ
bispecif
antibodi
fusion
protein
consist
two
componentson
bind
high
affin
fiber
knob
bind
high
specif
target
tissuespecif
receptor
dmitriev
et
al
dougla
et
al
haisma
et
al
haisma
et
al
nettelbeck
et
al
parrott
et
al
strategi
howev
twocompon
natur
bispecif
molecul
add
complic
manufactur
vector
also
maintain
batchtobatch
homogen
furthermor
modif
genet
progeni
virion
would
devoid
modif
therefor
genet
modif
capsid
protein
favor
option
genet
target
fiber
knob
receptorseek
moieti
chosen
incorpor
foreign
target
ligand
two
locat
c
terminu
hi
loop
fiber
knob
identifi
accept
modif
least
constraint
incorpor
rgd
polylysin
ligand
locat
led
enhanc
ad
infect
wide
varieti
target
cell
exampl
tumor
cell
dc
overexpress
integrin
hspg
respect
dmitriev
et
al
koizumi
et
al
wickham
et
al
wu
et
al
besid
fiber
knob
capsid
protein
hexon
penton
pix
piii
also
investig
alter
vector
tropism
cellspecif
ligand
incorpor
glasgow
et
al
vellinga
et
al
vign
et
al
wu
et
al
util
affibodi
librari
screen
approach
cellspecif
target
ligand
identifi
incorpor
ad
capsid
form
stabl
virion
belousova
et
al
hen
et
al
nord
et
al
anoth
insight
scheme
confer
novel
tropism
vector
substitut
fiberknob
ad
serotyp
util
noncar
receptor
intern
approach
also
known
pseudotyp
chimer
vector
carri
fiberknob
sever
serotyp
nonhuman
ad
canin
adenoviru
cav
serotyp
ovin
adenoviru
oav
serotyp
gener
show
improv
transduct
ovarian
cancer
malign
glioma
head
neck
cancer
model
breidenbach
et
al
glasgow
et
al
kanerva
et
al
nakayama
et
al
ni
et
al
nicol
et
al
rea
et
al
stoffkhalili
et
al
ulasov
et
al
zheng
et
al
despit
novel
tropism
fiberknob
compon
chimer
ad
vector
still
get
neutral
hexonspecif
antibodi
therefor
rare
serotyp
nonhuman
ad
bangari
mittal
develop
investig
altern
vector
gene
deliveri
ad
preval
human
popul
distinct
receptor
usag
thu
offer
potenti
advantag
vector
vector
base
nonhuman
ad
origin
deriv
pig
porcin
adenoviru
serotyp
cattl
bovin
adenoviru
serotyp
develop
bangari
mittal
mittal
et
al
reddi
et
al
b
demonstr
preexist
crossneutr
antibodi
human
importantli
antibodi
crossneutr
bangari
et
al
moffatt
et
al
vector
effici
transduc
human
murin
cell
cultur
intern
vector
carand
integrinindepend
bangari
mittal
bangari
et
al
b
vivo
studi
mice
also
indic
alter
biodistribut
pattern
vector
compar
vector
sharma
et
al
press
similarli
vector
deriv
canin
ad
ovin
ad
chimpanze
ad
murin
ad
fowl
ad
also
develop
bangari
mittal
recent
cellbas
deliveri
ad
vector
emerg
novel
deliveri
approach
cell
infect
ad
vitro
carri
ad
vector
target
tissu
power
et
al
nonreceptormedi
ad
transduct
system
prevent
vector
neutral
antiad
antibodi
elicit
desir
therapeut
effect
power
et
al
transcript
target
anoth
approach
involv
placement
critic
viral
transcript
unit
therapeut
gene
target
tissuespecif
regulatori
element
tre
nettelbeck
result
express
therapeut
gene
andor
viru
replic
expect
occur
select
preferenti
target
cell
earli
gene
ad
common
choic
control
tre
express
first
essenti
viral
replic
essenti
earli
gene
either
alon
combin
also
exogen
control
impart
tissu
specif
ad
vector
doronin
et
al
kawashima
et
al
ko
et
al
kuppuswami
et
al
li
et
al
rodriguez
et
al
similar
mani
virus
ad
evolv
util
redund
receptor
abundantli
express
wide
varieti
cell
throughout
bodi
cell
invas
variou
studi
unravel
varieti
cell
surfac
molecul
involv
ad
entri
demonstr
interact
viral
capsid
protein
review
discuss
cellular
surfac
molecul
includ
car
integrin
sialic
acid
proteoglycan
hspg
mhci
identif
addit
ad
receptor
elud
recognit
sinc
long
widen
repertoir
ad
receptor
would
import
unravel
complex
viru
tropism
pathogenesi
moreov
knowledg
ad
cell
receptor
interact
enabl
us
design
specif
vector
target
specif
tissu
organ
ablat
natur
tropism
andor
incorpor
new
ligand
may
lead
reduct
vector
dose
vivo
toxic
evad
preexist
immun
respons
ad
vector
date
numer
strategi
investig
modul
tropism
ad
vector
result
improv
safeti
efficaci
evid
promis
preclin
well
clinic
data
aghi
martuza
rein
et
al
differ
receptor
usag
ad
serotyp
provid
uniqu
opportun
exploit
natur
divers
ad
tropism
design
vector
divers
gene
therapi
applic
critic
identifi
suitabl
vector
candid
specif
effici
target
import
cell
type
prevent
therapeut
gene
deliveri
applic
notabl
receptor
identifi
date
util
ad
belong
ig
superfamili
addit
cell
surfac
compon
similar
structur
share
homolog
identifi
receptor
may
potenti
function
least
low
affin
attach
receptor
either
alon
combin
multipl
molecul
stabil
viru
particl
facilit
access
intern
receptor
cell
surfac
though
receptor
bind
thought
one
key
determin
ad
tissu
tropism
suffici
explain
aspect
vivo
hostviru
interact
instanc
enhanc
transduct
liver
cell
ad
uptak
kupffer
cell
appear
independ
receptor
usag
better
understand
structur
function
interact
ad
host
cellsprotein
requir
ration
design
effect
safe
vector
addit
knowledg
ad
viruscel
interact
could
aid
make
improv
vector
system
nonvir
vector
util
ad
transloc
pathway
obtain
effect
gene
drug
transfer
